Navigation Links
Enhanced U.S. Efforts to Fight Tropical Disease Offer Hope to Millions of Patients
Date:2/22/2008

Pharmaceutical Companies' Donations of Medicines Remain Key Component

WASHINGTON, Feb. 22 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement on President Bush's proposal to increase the United States' efforts to battle neglected tropical diseases in the developing world:

"America's pharmaceutical research companies applaud President Bush's proposal to increase the United States' commitment to fight neglected tropical diseases (NTDs) such as trachoma, schistosomiasis, and river blindness. Many of these diseases are preventable and treatable, and this tremendous support -- coupled with the ongoing efforts by pharmaceutical companies -- offers great hope that we can bring an end to the devastation they cause.

"Today, most drugs to treat these diseases are donated by pharmaceutical companies -- at an estimated value in the hundreds of millions of dollars annually. Beyond the direct therapeutic benefit for patients, the contributions of these drugs also have a meaningful economic impact on the battle against disease in the developing world. In Sub-Saharan Africa, these donations have helped to lower the estimated cost of an effective program to fight NTDs to less than 40 cents per person per year, according to the White House.

"Researchers and scientists from America's pharmaceutical research companies are proud to have worked to develop effective treatments for a wide range of NTDs, and will be honored to accept President Bush's challenge to increase global action in this fight. Together, we can combat NTDs and significantly improve the lives of families and communities across Africa."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America(PhRMA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
2. The HealthCentral Network and Sister to Sister Form Alliance to Develop Enhanced Online Resources
3. T cell immunity enhanced by timing of interleukin-7 therapy
4. Brookdale Senior Living Announces Enhanced Web Site
5. NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
6. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
7. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
8. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
9. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
10. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
11. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, the healthcare ... podcast, “Make Plans for MACRA,” highlighting the impact of the Medicare ... and how physicians and other clinicians are reimbursed for the care they deliver ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs today is releasing ... measured in Part D Medicare data. The dataset, called PaPR (Providers and Prescribing ... faxes or paper. The PaPR (pronounced "paper") data set aggregates this information ...
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business Research Institute ... Registry of Emergency Medical Technicians and welcomes this organization to the NBRI ... G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
Breaking Medicine Technology: